Sc. Standard et al., BALLOON TEST OCCLUSION OF THE INTERNAL CAROTID-ARTERY WITH HYPOTENSIVE CHALLENGE, American journal of neuroradiology, 16(7), 1995, pp. 1453-1458
Citations number
17
Categorie Soggetti
Neurosciences,"Radiology,Nuclear Medicine & Medical Imaging
PURPOSE: To evaluate the usefulness of provocative testing with hypote
nsive challenge during balloon test occlusion of the internal carotid
artery before carotid sacrifice and to correlate tolerance of balloon
test occlusion with clinical outcome after carotid artery sacrifice. M
ETHODS: Forty-seven consecutive cases of balloon test occlusions perfo
rmed at our institution during the past 4 years were retrospectively r
eviewed, Occlusion was performed under normotensive conditions with di
stal perfusion of heparinized saline for 20 minutes, or until a defici
t was perceived. If 20 minutes of normotension was tolerated, hypotens
ion was induced to two thirds of mean arterial pressure for 20 minutes
, or until a deficit was perceived. RESULTS: Of 47 patients, 4 (9%) ha
d deficits at normotension. Of the remaining 43 patients, 9 (21%) had
deficits at hypotension. One patient with a positive hypotensive test
occlusion underwent carotid artery sacrifice after extracranial-intrac
ranial bypass without sequelae. In one of the 19 patients who clinical
ly tolerated test occlusion with hypotension and had carotid sacrifice
(surgical ligation of the intracranial carotid artery), a mild emboli
c stroke developed, probably from the giant carotid wall aneurysm. Thi
s patient fully recovered; MR imaging showed mild changes consistent w
ith emboli distal to the aneurysm. Symptomatic complications were note
d in 2 (4%) patients, and asymptomatic arterial dissections were noted
in 3 (6%) patients. CONCLUSION: Balloon test occlusion with hypotensi
ve challenge is safe, economical, and greatly increases the sensitivit
y of balloon test occlusion. The predictive;value of a negative test i
s high. However, to determine the test's specificity compared with qua
ntitative imaging, controlled trials will be necessary.